N.‐G. Ilbäck

818 total citations
21 papers, 542 citations indexed

About

N.‐G. Ilbäck is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, N.‐G. Ilbäck has authored 21 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in N.‐G. Ilbäck's work include Viral Infections and Immunology Research (9 papers), Exercise and Physiological Responses (5 papers) and Virus-based gene therapy research (3 papers). N.‐G. Ilbäck is often cited by papers focused on Viral Infections and Immunology Research (9 papers), Exercise and Physiological Responses (5 papers) and Virus-based gene therapy research (3 papers). N.‐G. Ilbäck collaborates with scholars based in Sweden, United States and Australia. N.‐G. Ilbäck's co-authors include G Friman, Jan Fohlman, W. R. Beisel, Kristin Larsson, Leonardo Merino, Per Ola Darnerud, Torbjörn Stålhandske, Karlis Pauksen, Anders Glynn and Daniel J. Crawford and has published in prestigious journals such as The Journal of Immunology, The Journal of Infectious Diseases and European Heart Journal.

In The Last Decade

N.‐G. Ilbäck

21 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N.‐G. Ilbäck Sweden 16 171 137 94 78 68 21 542
Vedat Bulut Türkiye 14 30 0.2× 103 0.8× 39 0.4× 76 1.0× 111 1.6× 25 610
Adam M. Hammer United States 11 153 0.9× 46 0.3× 51 0.5× 232 3.0× 67 1.0× 18 588
Konstantinos Tzirogiannis Greece 13 66 0.4× 62 0.5× 50 0.5× 49 0.6× 59 0.9× 30 538
Susan Green United States 8 97 0.6× 40 0.3× 20 0.2× 102 1.3× 26 0.4× 13 806
Marina Djelić Serbia 13 135 0.8× 55 0.4× 34 0.4× 244 3.1× 16 0.2× 39 835
Isabel Llompart Spain 19 49 0.3× 143 1.0× 114 1.2× 115 1.5× 19 0.3× 32 888
Whitney L Breslin United States 12 35 0.2× 28 0.2× 39 0.4× 67 0.9× 94 1.4× 19 529
S L Gaffin South Africa 11 59 0.3× 27 0.2× 217 2.3× 86 1.1× 78 1.1× 22 681
Tobias Ibfelt Denmark 10 31 0.2× 64 0.5× 330 3.5× 89 1.1× 31 0.5× 14 606
Elham Alipoor Iran 14 44 0.3× 77 0.6× 41 0.4× 134 1.7× 18 0.3× 39 588

Countries citing papers authored by N.‐G. Ilbäck

Since Specialization
Citations

This map shows the geographic impact of N.‐G. Ilbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.‐G. Ilbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.‐G. Ilbäck more than expected).

Fields of papers citing papers by N.‐G. Ilbäck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.‐G. Ilbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.‐G. Ilbäck. The network helps show where N.‐G. Ilbäck may publish in the future.

Co-authorship network of co-authors of N.‐G. Ilbäck

This figure shows the co-authorship network connecting the top 25 collaborators of N.‐G. Ilbäck. A scholar is included among the top collaborators of N.‐G. Ilbäck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.‐G. Ilbäck. N.‐G. Ilbäck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glynn, Anders, et al.. (2017). Are additive effects of dietary surfactants on intestinal tight junction integrity an overlooked human health risk? – A mixture study on Caco-2 monolayers. Food and Chemical Toxicology. 106(Pt A). 314–323. 28 indexed citations
2.
Larsson, Kristin, Per Ola Darnerud, N.‐G. Ilbäck, & Leonardo Merino. (2011). Estimated dietary intake of nitrite and nitrate in Swedish children. Food Additives & Contaminants Part A. 28(5). 659–666. 45 indexed citations
3.
Ilbäck, N.‐G., et al.. (2004). Do surface-active lipids in food increase the intestinal permeability to toxic substances and allergenic agents?. Medical Hypotheses. 63(4). 724–730. 30 indexed citations
4.
Ilbäck, N.‐G. & Torbjörn Stålhandske. (2003). Cardiovascular effects of xylazine recorded with telemetry in the dog. Journal of Veterinary Medicine Series A. 50(10). 479–483. 15 indexed citations
5.
Ilbäck, N.‐G., et al.. (2003). Estimated intake of the artificial sweeteners acesulfame-K, aspartame, cyclamate and saccharin in a group of Swedish diabetics. Food Additives & Contaminants. 20(2). 99–114. 38 indexed citations
6.
Friman, G & N.‐G. Ilbäck. (1998). Acute Infection: Metabolic Responses, Effects on Performance, Interaction with Exercise, and Myocarditis. International Journal of Sports Medicine. 19(S 3). S172–S182. 53 indexed citations
7.
Ilbäck, N.‐G., et al.. (1995). New aspects of murine coxsackie B3 myocarditis--focus on heavy metals. European Heart Journal. 16(suppl O). 20–24. 22 indexed citations
8.
Fohlman, Jan, et al.. (1993). High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis.. PubMed. 88. 103–8. 35 indexed citations
9.
Waldenström, Anders, G. Ronquist, Jan Fohlman, Bengt Gerdin, & N.‐G. Ilbäck. (1993). Ionophoric interaction with the myocyte sarcolemma: a new insight into the pathophysiology of degenerative myocardial disease.. PubMed. 88. 131–4. 5 indexed citations
10.
Ilbäck, N.‐G., Lars Wesslén, Karlis Pauksen, et al.. (1993). Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease.. PubMed. 88. 117–23. 22 indexed citations
11.
Ilbäck, N.‐G., Jan Fohlman, & G Friman. (1993). Altered distribution of heavy metals and lipids in coxsackievirus B3 infected mice.. PubMed. 88. 93–8. 2 indexed citations
12.
Friman, G & N.‐G. Ilbäck. (1992). Exercise and infection – interaction, risks and benefits. Scandinavian Journal of Medicine and Science in Sports. 2(4). 177–189. 11 indexed citations
13.
Fohlman, Jan, G Friman, N.‐G. Ilbäck, Agneta Åkesson, & Sally A. Huber. (1990). A qualitative and quantitative method for in situ characterization of the inflammatory response in experimental myocarditis. Apmis. 98(1-6). 559–567. 15 indexed citations
14.
Ilbäck, N.‐G., et al.. (1990). Cardiovascular lipid accumulation with Coxsackie B virus infection in mice.. PubMed. 136(1). 159–67. 42 indexed citations
15.
Ilbäck, N.‐G., et al.. (1989). Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis.. The Journal of Immunology. 142(9). 3225–3228. 44 indexed citations
16.
Friman, Göran, James E. Wright, N.‐G. Ilbäck, et al.. (1985). Does Fever or Myalgia Indicate Reduced Physical Performance Capacity in Viral Infections?. Acta Medica Scandinavica. 217(4). 353–361. 28 indexed citations
17.
Ilbäck, N.‐G., et al.. (1984). Modifying effects of exercise on clinical course and biochemical response of the myocardium in influenza and tularemia in mice. Infection and Immunity. 45(2). 498–504. 41 indexed citations
18.
Ilbäck, N.‐G., et al.. (1984). Sequential metabolic alterations in the myocardium during influenza and tularemia in mice. Infection and Immunity. 45(2). 491–497. 23 indexed citations
19.
Friman, G, N.‐G. Ilbäck, W. R. Beisel, & Daniel J. Crawford. (1982). The Effects of Strenuous Exercise on Infection with Francisella tularensis in Rats. The Journal of Infectious Diseases. 145(5). 706–714. 30 indexed citations
20.
Friman, G, N.‐G. Ilbäck, & Lars Pilström. (1981). Skeletal muscle lactate dehydrogenase isozymes and fibre composition in viral, mycoplasma and bacterial infections in young and old men. Scandinavian Journal of Clinical and Laboratory Investigation. 41(6). 551–556. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vedat Bulut Breakdown of academic impact, for papers by Adam M. Hammer Breakdown of academic impact, for papers by Konstantinos Tzirogiannis Breakdown of academic impact, for papers by Susan Green Breakdown of academic impact, for papers by Marina Djelić Breakdown of academic impact, for papers by Isabel Llompart Breakdown of academic impact, for papers by Whitney L Breslin Breakdown of academic impact, for papers by S L Gaffin Breakdown of academic impact, for papers by Tobias Ibfelt Breakdown of academic impact, for papers by Elham Alipoor
Rankless by CCL
2026